Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Global University Venturing

Cardihab nudges investors for $1.35m

Multi-university venturing fund Uniseed has invested $500,000 in smartphone cardiac monitoring developer Cardihab.


Sep 22, 2017

Interface Polymers bags $2.6m

Interface Polymers has secured funding as it prepares to shape its materials adhesive concept into a commercial product.

Sep 22, 2017

Medaphor picks up Intelligent Ultrasound

Ultrasound simulator developer Medaphor will pay up to $4.9m in shares to acquire University of Oxford spinout Intelligent Ultrasound.

Sep 22, 2017

Contrary Capital boots up fund

The fund, which has already made its first investments, will offer between $50,000 and $200,000 to both spinouts and student startups.

Sep 22, 2017

Analysis: MissFresh gets $230m delivered

Returning investor Tencent contributed to a round that upped the total raised by the online fresh produce retailer to over $400m

Sep 22, 2017

Disarm persuades investors for series A

AbbVie Ventures is among the backers of a $30m series A round for Disarm Therapeutics, a biotechnology spinout from Washington University in St Louis.

Sep 21, 2017

The Engine accelerates to $200m

The Engine has already made seven investments in a bid to commercialise technologies that require a longer-term view than most.

Sep 20, 2017

IP Group secures 96.5% of Touchstone support

The commercialisation firm has secured support for a takeover from shareholders who hold 96.5% between them in its peer Touchstone Innovations.

Sep 20, 2017

Ovensa scores $1.38m in capital

Uqar spinout Ovensa has obtained $1.38m of additional funding from investors including commercialisation firm Aligo Innovation.

Sep 19, 2017

Matroid meets Intel in $10m round

Intel and New Enterprise Associates have co-led a series A round for computer vision startup Matroid, based on research by Stanford professor Reza Zadeh.

Sep 19, 2017

Immunocore takes in up to $40m

Bill & Melinda Gates Foundation will invest up to $40m in the biological drug developer, which raised $320m in an Eli Lilly-backed round two years ago.

Sep 19, 2017
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here